证券代码：833429 证券简称：康比特 公告编号：2025-046 北京康比特体育科技股份有限公司 本次年度报告业绩说明会将采用网络方式召开，投资者可登陆全景网"投资 者关系互动平台"（http://ir.p5w.net）参与本次年度报告业绩说明会。 三、 参加人员 公司董事长：白厚增先生 公司董事、总经理：李奇庚女士 公司财务总监、董事会秘书：吕立甫先生 公司保荐代表人：洪吉通先生、刘冬先生 2024 年年度报告说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 北京康比特体育科技股份有限公司（以下简称"公司"）于 2025 年 4 月 18 日在北京证券交易所官方信息披露平台（http://www.bse.cn/）发布了《2024 年年度报告》及《2024 年年度报告摘要》，为方便广大投资者更深入了解公司 2024 年年度经营业绩的具体情况，加强与投资者的互动交流，公司拟召开 2024 年年 度报告业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：202 ...

证券代码：833429 证券简称：康比特 公告编号：2025-044 北京康比特体育科技股份有限公司 持股 5%以上股东减持股份结果公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 减持主体减持前基本情况 | 股东名称 | | 股东身份 | 持股数量（股） | 持股比例 | 当前持股股份来源 | | --- | --- | --- | --- | --- | --- | | 银晖国际有限公司 | 持股 | 5%以上股东 | 11,471,286 | 9.21% | 北京证券交易所上 | | | | | | | 市前取得 | 二、 减持计划的实施结果 （一） 股东因以下原因披露减持计划实施结果： √减持计划实施完毕 □减持时间区间届满 | | | 已减 | 减 | | 减持价格区 | | 减持 | 当前持股数 | 当前 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 已减持数 | 持 | 持 | 减持 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [3][5] Core Views - The company reported a revenue of 1.94 billion yuan in Q1 2025, representing a year-on-year increase of 26% and a net profit attributable to shareholders of 12.04 million yuan, up 10% year-on-year [5] - The company is focusing on high-end, differentiated competition, leveraging its brand, technology research and development, and sales channel advantages [5] - The company expects net profits for 2025-2027 to be 1.23 billion, 1.42 billion, and 1.83 billion yuan respectively, with corresponding EPS of 0.99, 1.14, and 1.47 yuan per share, indicating a positive outlook for its energy gel and whey protein products [5] Financial Summary - In 2024, the company achieved a revenue of 1.04 billion yuan, a year-on-year growth of 23.34%, and a net profit of 89.31 million yuan, a growth of 1.38% [5] - The gross margin for 2024 was 39.41%, a decrease of 0.69 percentage points from 2023 [5] - The company’s revenue is projected to grow from 1.33 billion yuan in 2025 to 1.92 billion yuan in 2027, with corresponding net profits increasing from 123 million yuan to 183 million yuan [9] Product Innovation and Market Expansion - The company launched a higher quality CPT pro specialized nutrition whey protein in 2024, leading to a 72.64% increase in revenue from protein muscle gain products [6] - The company developed a new 7-layer energy gel, achieving a revenue of 38.79 million yuan in 2024, a year-on-year increase of 48.64% [6] - The company collaborated with nearly 470 events, including marathons and trail races, in 2024, enhancing brand exposure and market influence [7]

Investment Rating - The investment rating for the company is "Buy" (maintained) [3][5] Core Views - The company reported a revenue of 1.94 billion yuan in Q1 2025, representing a year-on-year increase of 26% and a net profit attributable to shareholders of 12.04 million yuan, up 10% year-on-year [5] - The company is focusing on high-end, differentiated competition, leveraging its brand, technology research and development, and sales channel advantages [5] - The company expects net profits for 2025-2027 to be 1.23 billion, 1.42 billion, and 1.83 billion yuan respectively, with corresponding EPS of 0.99, 1.14, and 1.47 yuan per share, indicating a positive outlook for its energy gel and whey protein products [5] Financial Summary - In 2024, the company achieved a revenue of 1.04 billion yuan, a year-on-year growth of 23.34%, and a net profit of 89.31 million yuan, a growth of 1.38% [5][9] - The gross margin for 2024 was 39.41%, a decrease of 0.69 percentage points from 2023 [5] - The company’s revenue is projected to grow from 1.33 billion yuan in 2025 to 1.92 billion yuan in 2027, with corresponding net profits increasing from 123 million yuan to 183 million yuan [9] Product Innovation and Market Expansion - The company launched a higher quality CPT pro specialized nutrition whey protein in 2024, leading to a 72.64% increase in revenue from protein muscle gain products [6] - The company developed a new 7-layer energy gel and established core patents for high branched cyclic dextrin combinations, resulting in a 48.64% increase in energy gel revenue [6] - The company collaborated with nearly 470 events, including marathons and trail races, in 2024, enhancing brand exposure and market influence [7]

Core Viewpoint - Company 康比特 has reported record-high revenue and net profit for 2024, indicating strong profitability and growth momentum, driven by the dual trends of "sports nutrition + health consumption" [1] Financial Performance - In 2024, 康比特 achieved revenue of 1.04 billion yuan, a year-on-year increase of 23.34%, with a compound annual growth rate (CAGR) exceeding 30% from 2020 to 2024 [1] - The company reported a net profit of 87.17 million yuan, up 15.07% year-on-year, with a CAGR exceeding 60% from 2020 to 2024 [1] - For Q1 2025, 康比特's revenue was 194 million yuan, a 26.08% increase year-on-year, and net profit was 12.04 million yuan, up 9.66% year-on-year [1] Business Segments - The military supply business saw a revenue decline of 45.1% in 2024, totaling 132.44 million yuan, primarily due to the cyclical nature of military procurement [2] - Despite the decline, 康比特 maintained a leading position in military procurement, and future demand for military products is expected to remain strong due to ongoing national defense modernization [2] Industry Trends - The sports nutrition industry is entering a golden development period, driven by the "Healthy China" strategy and consumption promotion policies [3] - The market for sports nutrition products in China has significant growth potential, as awareness and consumption habits are still developing compared to developed countries [3] - Recent government initiatives, such as the "Weight Management Year" action plan, are expected to boost demand for weight control products, including protein supplements [4] Product Development - 康比特's core products, particularly protein muscle gain products, have seen significant revenue growth, with a 72.64% increase to 52.91 million yuan in 2024 [5] - The company plans to establish four product project teams focusing on protein muscle gain, energy supplementation, weight control, and professional sports markets to enhance resource integration and market responsiveness [5] Sales Strategy - 康比特 has implemented a robust channel strategy, expanding distribution through traditional e-commerce and new media channels, and engaging consumers through events and competitions [6] - The company has reached 4.24 million runners through 470 events in 2024, leveraging its partnership with the Chinese Athletics Association [6] Market Outlook - Analysts project 康比特's net profit to reach 115 million yuan in 2025, with a corresponding price-to-earnings (PE) ratio of 28 [7] - The company is viewed as an attractive investment opportunity in the sports nutrition sector, with a current stock price that is considered undervalued compared to its growth potential [7]

Investment Rating - The report maintains an "Outperform" rating for the company [2][10]. Core Insights - The company reported a total revenue of 1.04 billion yuan in 2024, representing a year-on-year growth of 23.3%, and a net profit attributable to shareholders of 89 million yuan, with a growth of 1.4% [7]. - The company has a strong market position in the sports nutrition sector, with significant growth in core product categories such as protein supplements and energy products, driven by innovative product development and effective marketing strategies [7][10]. - The company is expected to benefit from the upcoming peak season for sports and fitness, particularly during the marathon events in April and May [10]. Financial Data and Profit Forecast - The company’s projected revenues for 2025 are estimated at 1.41 billion yuan, with a year-on-year growth rate of 35.2% [6]. - The net profit for 2025 is forecasted to be 115 million yuan, reflecting a growth of 29.3% compared to the previous year [6]. - The gross margin for 2024 was reported at 39.4%, slightly down from the previous year, primarily due to rising costs of whey protein [7][10]. - The company’s earnings per share (EPS) for 2025 is projected to be 0.93 yuan [6]. Revenue Breakdown - In 2024, the revenue from sports nutrition products accounted for 75.9% of total revenue, with significant contributions from protein and energy supplements, which grew by 72.6% and 71.7% respectively [7]. - The military supply business generated 132 million yuan in revenue, although it saw a decline of 45.1% due to changes in procurement cycles [7]. - The company is actively increasing its inventory of whey protein to manage production costs effectively [7][10].

证券代码：833429 证券简称：康比特 公告编号：2025-037 北京康比特体育科技股份有限公司 关于召开 2024 年年度股东大会通知公告（提供网络投票） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开基本情况 （一）股东大会届次 本次会议为 2024 年年度股东大会。 （二）召集人 本次股东大会的召集人为董事会。 根据《中华人民共和国公司法》（以下简称"《公司法》"）和《北京康比 特体育科技股份有限公司章程》（以下简称"《公司章程》"）的有关规定，北 京康比特体育科技股份有限公司（以下简称"公司"）于 2025 年 4 月 16 日召 开第六届董事会第十一次会议，审议通过了《关于提请召开公司 2024 年年度 股东大会的议案》。 2、网络投票起止时间：2025 年 5 月 8 日 15:00—2025 年 5 月 9 日 15:00。 登记在册的股东可通过中国证券登记结算有限责任公司（以下简称"中国结 算"）持有人大会网络投票系统对有关议案进行投票表决，为有利于投票意见的 顺利提交 ...

北京康比特体育科技股份有限公司 第六届监事会第十次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 证券代码：833429 证券简称：康比特 公告编号：2025-019 本次会议的召开符合《公司法》和《公司章程》的有关规定。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 二、议案审议情况 （一）审议通过《2024 年年度报告及摘要》 1.议案内容： 公司 2024 年度报告及摘要的编制和保密程序符合法律、法规、公司章程 和公司管理制度的各项规定；本次年度报告及摘要的内容和格式符合中国证监 会和北京证券交易所的各项规定，其内容真实、准确、完整，不存在任何虚假 记载、误导性陈述或者重大遗漏，报告客观地反映了公司 2024 年度的财务及 经营状况，并由容诚会计师事务所（特殊普通合伙）出具了标准无保留意见的 1.会议召开时间：2025 年 4 月 16 日 2.会议召开地点：公司会议室 3.会议召开方式：现场和通讯 4.发出监事 ...

证券代码：833429 证券简称：康比特 公告编号：2025-018 北京康比特体育科技股份有限公司 第六届董事会第十一次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 会议应出席董事 7 人，出席和授权出席董事 7 人。 二、议案审议情况 公司 2024 年度报告及摘要的编制和保密程序符合法律、法规、公司章程 和公司管理制度的各项规定；本次年度报告及摘要的内容和格式符合中国证监 会和北京证券交易所的各项规定，其内容真实、准确、完整，不存在任何虚假 记载、误导性陈述或者重大遗漏，报告客观地反映了公司 2024 年度的财务及 1.会议召开时间：2025 年 4 月 16 日 2.会议召开地点：公司会议室 3.会议召开方式：现场和通讯 4.发出董事会会议通知的时间和方式：2025 年 4 月 6 日以书面方式发出 5.会议主持人：白厚增 6.会议列席人员：公司监事、高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议的召开符合《公司法》和《 ...

证券代码：833429 证券简称：康比特 公告编号：2025-020 北京康比特体育科技股份有限公司 2024 年年度权益分派预案公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 2025 年 4 月 16 日，北京康比特体育科技股份有限公司（以下简称"康比 特"或"公司"）第六届董事会第十一次会议及第六届监事会第十次会议审议 通过《2024 年度利润分配方案》，公司权益分派预案如下： 一、权益分派预案情况 根据公司 2025 年 4 月 18 日披露的 2024 年年度报告（财务报告已经审计）， 截至 2024 年 12 月 31 日，上市公司合并报表归属于母公司的未分配利润为 401,729,879.04 元，母公司未分配利润为 392,302,442.61 元。 公司本次权益分派预案如下：公司目前总股本为 124,500,000 股，根据扣除 回购专户 1,366,126 股后的 123,133,874 股为基数，以未分配利润向全体股东每 10股派发现金红利2.5元（含税）。本次权益分派共预计 ...